Vaccinate Without Testing or Simply Continue the Series
For a 30-year-old woman with uncertain hepatitis B vaccination history, you should proceed directly with vaccination without requiring serologic testing, as lack of access to testing should not be a barrier to protecting susceptible persons 1.
Practical Approach
You have two straightforward options:
Option 1: Vaccinate Without Testing (Preferred in Most Settings)
- Start a complete hepatitis B vaccine series immediately
- No need to obtain prevaccination serologies (HBsAg, anti-HBs, anti-HBc)
- This approach is explicitly endorsed by ACIP 2022 guidelines, which state that "testing is not a requirement for vaccination, and in settings where testing is not feasible, vaccination of persons recommended to receive the vaccine should continue" 1
- There is no harm in revaccinating someone who may already be immune—the vaccine is safe even if she previously completed the series
Option 2: Test First (If Resources Available and Patient Willing to Wait)
If you have easy access to serologic testing and the patient can return for results:
- Order triple panel: HBsAg, anti-HBs, and anti-HBc
- If anti-HBs positive: already immune, no vaccination needed
- If all negative: proceed with full series
- If HBsAg positive: refer for chronic hepatitis B management
Recommended Vaccine Regimens for Adults ≥20 Years
Choose one of these options 1:
Fastest completion (recommended for better adherence):
- Heplisav-B: 2 doses at 0 and 1 month (20 μg, 0.5 mL each)
Standard 3-dose options:
- Engerix-B: 3 doses at 0,1, and 6 months (20 μg, 1 mL each)
- Recombivax HB: 3 doses at 0,1, and 6 months (10 μg, 1 mL each)
- PreHevbrio: 3 doses at 0,1, and 6 months (10 μg, 1 mL each)
If she needs hepatitis A protection too:
- Twinrix: 3 doses at 0,1, and 6 months (standard schedule)
Key Clinical Considerations
If She's Pregnant or Planning Pregnancy
- Avoid Heplisav-B and PreHevbrio (insufficient pregnancy safety data)
- Use Engerix-B, Recombivax HB, or Twinrix instead 1
If the Series Gets Interrupted
- Never restart the series from the beginning 1
- Simply give the next dose as soon as possible
- Minimum intervals for 3-dose series:
- Between doses 1 and 2: 4 weeks
- Between doses 2 and 3: 8 weeks
- Between doses 1 and 3: 16 weeks
Why Universal Vaccination at Age 30
This patient falls squarely within the ACIP 2022 universal vaccination recommendation for all adults aged 19-59 years 1, 2. This represents a major shift from previous risk-based approaches that failed because they required patients to recognize and disclose risk factors, leading to suboptimal coverage. The universal approach eliminates the need for risk assessment and disclosure 2.
Common Pitfalls to Avoid
- Don't delay vaccination waiting for records—proceed with vaccination now
- Don't assume she's immune just because she "might have been vaccinated"—only 30% of US adults are actually vaccinated 3
- Don't order postvaccination titers routinely—only needed for healthcare workers, immunocompromised patients, or those on hemodialysis
- Don't use Heplisav-B if she's on hemodialysis or immunocompromised—safety not established in these populations 1
The 2-dose Heplisav-B regimen offers the best real-world completion rates and should be your first choice for this patient unless she's pregnant or planning pregnancy 2.